A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy

Kotaro Kuwaki(Kurume University), Takuji Torimura(Omuta hospital), Shuhei Fukunaga(Kurume University), Toshi Abe(Kurume University), Keiichi Mitsuyama(Kurume University), Hidetoshi Takedatsu(Kurume University), Hayato Kaida(Active Medicine (United Kingdom)), Ryosuke Yamauchi(Kurume University), Shinichiro Yoshioka(Kurume University), Hiroshi Yamasaki(Museum für Naturkunde), Osamu Tsuruta(Kurume University)
Cytotherapy
December 17, 2015
10.1016/j.jcyt.2015.10.010
Cited by 12

Related Papers

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600